Search for: [Abstract = "Background\: The introduction of 24\/7 primary PCI service increases theaccessibility of invasive diagnosis and improves the results of treatment of patientssuffering from acute coronary syndromes.Aim\: The aim of the study was to analyse the characteristics of patients with acutemyocardial infarction with and without the ST\-segment elevation \(STEMI,NSTEMI\) and the assessment of the effects of implementing various treatmentmethods in those groups \(non\-invasive treatment, reperfusion – lytic therapy,pharmacomechanical therapy\), and also to establish the benefits of the introductionof the 24\/7 primary PCI service.Methods\: The analysis included in total 451 patients suffering from the acutecoronary syndrome. The enrollment continued for 12 months \- period I \(19.04.2004– 19.04.2005\), before the introduction of the 24\/7 primary PCI service and 15months – period II \(8.08.2005 – 19.10.2006\), after the introduction of the 24\/7primary PCI service. The registered patients were divided into four groups\: STEMIgroup in period I \(n = 115\), NSTEMI group in period I \(n = 113\), STEMI group inperiod II \(n = 111\), NSTEMI group in period II \(n = 112\). The STEMI patients inperiod I received non\-invasive treatment \(n = 59\), facilitated PCI \(n = 32\) and lytics\- streptokinase \(n = 24\), but during period II all the patients underwent the primaryPCI. The NSTEMI patients in period I underwent coronary angiography duringhospital stay and in period II received the early invasion treatment on the earlyinvasive strategy \(coronary angiography was performed within 48 hours\). All groupswere followed for 1 year.Results\: The STEMI groups of patients received the following therapy – in period Iinvasive treatment 48,7% \(facilitated PCI 27,8% and lytics 20,9%\), in period II allpatients underwent primary PCI. The in\-hospital mortality of the patients withSTEMI in period I receiving the non\-invasive treatment was 23,7%. The STEMI Igroup with pharmacoinvasive approach had better outcome – the in\-hospitalmortality was 9,4%, and in the group undergoing primary PCI \(STEMI II\) 5,4%. Thebenefit of invasive treatment was seen during 1\-year of follow\-up. The NSTEMIgroup of patients underwent PCI during hospital stay respectively 38,0% in period Iand 89,3% in period II. The patients of the NSTEMI group sub\-classified as the highrisk patients according to the TIMI Risk Score \(5 points and more\) had worseprognosis in comparison to the sub\-group of the low and intermediate risk \(the inhospitaland 1\-year mortality in period I were 3,6% vs 0,0%, p=0,15 and 10,9% vs3,5%, p=0,13, in period II respectively 3,8% vs 0,0%, p =0,13 and 9,4% vs 1,7%,p=0,07\). The outcome of the high risk NSTEMI population was comparable withSTEMI patients group \(the 1\-year mortality rate is 9,0% vs 9,4%\). The patients in"]

Number of results: 0